Susquehanna International Group’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.55M Buy
555,702
+268,783
+94% +$818K ﹤0.01% 6791
2025
Q4
$1.19M Sell
286,919
-159,659
-36% -$841K ﹤0.01% 6790
2025
Q3
$1.89M Buy
446,578
+253,378
+131% +$953K ﹤0.01% 5916
2025
Q2
$408K Buy
193,200
+181,855
+1,603% +$272K ﹤0.01% 9631
2025
Q1
$13.8K Buy
11,345
+1,092
+11% +$1.53K ﹤0.01% 12190
2024
Q4
$13.2K Sell
10,253
-71,214
-87% -$171K ﹤0.01% 11962
2024
Q3
$224K Sell
81,467
-120,868
-60% -$297K ﹤0.01% 10237
2024
Q2
$457K Sell
202,335
-157,521
-44% -$479K ﹤0.01% 8476
2024
Q1
$860K Buy
359,856
+280,736
+355% +$531K ﹤0.01% 7245
2023
Q4
$131K Buy
79,120
+48,152
+155% +$93.4K ﹤0.01% 11092
2023
Q3
$59.5K Buy
30,968
+5,683
+22% +$9.35K ﹤0.01% 11216
2023
Q2
$36.4K Sell
25,285
-5,044
-17% -$8.55K ﹤0.01% 11456
2023
Q1
$63.7K Sell
30,329
-16,879
-36% -$27.3K ﹤0.01% 11581
2022
Q4
$53.3K Buy
47,208
+29,623
+168% +$39.5K ﹤0.01% 11357
2022
Q3
$29K Sell
17,585
-14,742
-46% -$27.5K ﹤0.01% 12456
2022
Q2
$42K Sell
32,327
-48,133
-60% -$69.2K ﹤0.01% 12069
2022
Q1
$130K Sell
80,460
-89,095
-53% -$172K ﹤0.01% 11703
2021
Q4
$351K Buy
169,555
+69,235
+69% +$198K ﹤0.01% 10105
2021
Q3
$389K Sell
100,320
-35,190
-26% -$119K ﹤0.01% 10001
2021
Q2
$434K Buy
135,510
+64,313
+90% +$229K ﹤0.01% 9929
2021
Q1
$154K Sell
71,197
-46,347
-39% -$104K ﹤0.01% 11637
2020
Q4
$263K Sell
117,544
-12,164
-9% -$31.9K ﹤0.01% 9540
2020
Q3
$347K Buy
129,708
+4,967
+4% +$13.9K ﹤0.01% 8414
2020
Q2
$382K Buy
124,741
+9,895
+9% +$24.9K ﹤0.01% 7898
2020
Q1
$225K Sell
114,846
-50,331
-30% -$122K ﹤0.01% 8482
2019
Q4
$472K Sell
165,177
-30,284
-15% -$105K ﹤0.01% 7094
2019
Q3
$717K Sell
195,461
-167,347
-46% -$605K ﹤0.01% 6466
2019
Q2
$1.51M Sell
362,808
-81,761
-18% -$354K ﹤0.01% 4751
2019
Q1
$2.27M Buy
444,569
+281,460
+173% +$1.35M ﹤0.01% 3562
2018
Q4
$559K Sell
163,109
-289,199
-64% -$1.38M ﹤0.01% 5805
2018
Q3
$2.72M Buy
452,308
+94,515
+26% +$520K ﹤0.01% 3504
2018
Q2
$2.28M Buy
357,793
+304,328
+569% +$1.48M ﹤0.01% 3796
2018
Q1
$253K Sell
53,465
-16,510
-24% -$76.9K ﹤0.01% 7916
2017
Q4
$234K Sell
69,975
-98,673
-59% -$249K ﹤0.01% 7992
2017
Q3
$358K Buy
168,648
+83,302
+98% +$165K ﹤0.01% 7093
2017
Q2
$210K Buy
+85,346
New +$227K ﹤0.01% 8206
2016
Q2
Sell
-13,250
Closed -$19.4K 8793
2016
Q1
$19K Sell
13,250
-14,660
-53% -$19.7K ﹤0.01% 8815
2015
Q4
$46K Buy
+27,910
New +$63.9K ﹤0.01% 9115
2015
Q3
Sell
-183,931
Closed -$434K 9775
2015
Q2
$502K Buy
183,931
+156,862
+579% +$473K ﹤0.01% 7629
2015
Q1
$91K Sell
27,069
-116,996
-81% -$418K ﹤0.01% 8995
2014
Q4
$500K Sell
144,065
-31,808
-18% -$141K ﹤0.01% 7201
2014
Q3
$885K Buy
175,873
+55,243
+46% +$430K ﹤0.01% 6166
2014
Q2
$1.67M Sell
120,630
-142,781
-54% -$1.78M ﹤0.01% 5009
2014
Q1
$4.03M Buy
263,411
+204,665
+348% +$2.91M ﹤0.01% 3194
2013
Q4
$475K Buy
+58,746
New +$543K ﹤0.01% 6787

Other funds holding GALT